Brenntag stock: analysis & valuation

BNR.DESpecialty ChemicalsGermanyData as of Nov 15, 2026
Metrics analysis · Specialty Chemicals

Brenntag BNR.DE

Price 58.66 EUR +2.12%Market cap 8.5 bn EUR52 weeks 43.72 – 66.86
Forward P/E
14.3x
Industry 15.7x
EV/EBITDA
10.5x
Industry 11.9x
Revenue growth
14.7%
Industry 7.9%
Operating margin
5.3%
Industry 12.2%
Return on equity
8.7%
Industry 8.7%
Free cash flow yield
3.5%
Industry 3.5%

What does Brenntag do?

Brenntag is a globally active distributor of industrial and specialty chemicals headquartered in Germany. The company acts as a link between chemical producers and a broad base of industrial customers. It buys products in large quantities, stores, blends and repackages them, and delivers them in quantities tailored to demand. In addition, there are services such as inventory management, container take-back, technical application advice, formulation support and help with regulatory requirements.

The company reports in two segments: Essentials and Specialties. Essentials mainly covers the broad business in industrial chemicals, while Specialties covers the more advice-intensive business in specialty products, for example for pharmaceuticals, nutrition, personal care, water treatment, coatings or construction applications. Earnings come predominantly from the margin between purchase and selling prices and from additional services. Competitively, Brenntag is among the world's leading chemical distributors; size, supplier relationships, logistics network and product variety are key positioning features.

Score profile

Quality3.2
Valuation7.4
Growth7.8
Financial strength4.8
Momentum5.0

Rank vs. Specialty Chemicals (43 companies). 10 = top of the group, 5 = middle. Calculated from the metrics below, without AI.

Metrics compared with the industry

On profitability and quality, Brenntag ranks below average in the group Specialty Chemicals (3.2/10). On growth, the company ranks above average in the group Specialty Chemicals (7.8/10). On valuation (higher = cheaper), the stock ranks above average in the group Specialty Chemicals (7.4/10). On financial strength, Brenntag ranks in the middle in the group Specialty Chemicals (4.8/10).

MetricStockGroup medianRanking
Forward P/E14.3x15.7xbetter than 62 %
Trailing P/E22.3x29.6xbetter than 77 %
PEG ratio1.1x2.0xbetter than 82 %
EV/EBITDA10.5x11.9xbetter than 59 %
Price/sales0.5x1.6xbetter than 92 %
Price/book1.8x2.3xbetter than 64 %
Revenue growth14.7%7.9%better than 87 %
Earnings growth14.1%0.0%better than 68 %
Gross margin25.8%31.7%better than 38 %
Operating margin5.3%12.2%better than 15 %
Net margin2.4%5.3%better than 24 %
Return on equity8.7%8.7%better than 50 %
Debt/equity84.2%68.5%better than 35 %
Current ratio1.9x1.8xbetter than 57 %
Free cash flow yield3.5%3.5%better than 50 %
Dividend yield3.2%1.8%–
Payout ratio72.2%48.8%–
Beta0.500.86–

Valuation: what is Brenntag worth?

Two valuation approaches – a discounted cash flow model and a valuation at the industry’s median multiples – give Brenntag a model range of 61.04 EUR to 96.82 EUR per share.

Price 58.66 EUR
Analysts 58.87 EUR
Fair value range 61.04 EUR – 96.82 EURMidpoint 68.76 EUR (+17.2% vs. price)

15 analysts, average rating “Hold”, average price target 58.87 EUR (+0.4%).

The full DCF matrix, the reverse DCF (what growth the price implies) and scenarios are part of the Pro analysis.

What the business depends on

  • Demand depends on industrial production in many customer industries and on the general economy.
  • Gross profit is determined by sales volumes, product mix and the spread between purchase and selling prices.
  • A dense logistics and warehouse network and long-standing supplier relationships secure economies of scale and market access.

Risks

  • Economic weakness in industrial sectors can weigh on sales volumes and utilization of the distribution and logistics network.
  • Fluctuating chemical prices and inventory valuations can affect margins and increase tied-up working capital.
  • Strict regulation and safety and environmental requirements carry liability, compliance and cost risks in the handling of hazardous substances.

What to look for with Brenntag

Operating profit relative to gross profit shows how efficiently Brenntag manages costs and actually turns the trading spread into profit.

Full AI analysis of Brenntag

The AI evaluates all the numbers above and turns them into an assessment with a score, strengths and weaknesses, a fair value range and risks – from €1.99; Plus (€4.99) adds business model, moat and scenarios, Pro (€9.99) also peer comparison and reverse DCF. See an example.

Analyze a stock

Results in minutes
1 Choose a stock
2 Choose the depth

See what you get first: Example Compact (Apple) PDF Plus example (Microsoft) PDF Example Pro (NVIDIA) PDF

3 Delivery
Secure payment via Stripe Report by email + PDF No subscription

Frequently asked questions about Brenntag stock

What is the P/E ratio of Brenntag stock?

Based on expected earnings, Brenntag trades at a P/E of 14.3x, compared with a median of 15.7x for the peer group Specialty Chemicals. Based on the earnings of the last twelve months it is 22.3x. (data as of Nov 15, 2026)

Does Brenntag pay a dividend?

Yes. The dividend yield is currently 3.2%, with a payout ratio of 72.2% of earnings.

Is Brenntag stock undervalued?

Measured by valuation metrics (P/E, EV/EBITDA, price/sales, PEG), Brenntag is currently valued cheaper than most companies in the group Specialty Chemicals (valuation score 7.4 out of 10). Our model calculations (DCF and industry multiples) give a range of 61.04 EUR to 96.82 EUR per share at a price of 58.66 EUR. This is a model calculation, not an investment recommendation.

What do analysts say about Brenntag stock?

15 analysts have an average price target of 58.87 EUR (+0.4% vs. the current price); the average rating is “Hold”. Analyst targets are opinions and change frequently.

Comparable stocks

All information without guarantee. Metrics from public market data, updated daily; company profile written editorially with the help of AI. Not investment advice and not a solicitation to buy or sell securities.